Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice
Open Access
- 8 November 2007
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 117 (12), 3900-3908
- https://doi.org/10.1172/jci33372
Abstract
HDLs protect against the development of atherosclerosis, but the underlying mechanisms are poorly understood. HDL and its apolipoproteins can promote cholesterol efflux from macrophage foam cells via the ATP-binding cassette transporters ABCA1 and ABCG1. Experiments addressing the individual roles of ABCA1 and ABCG1 in the development of atherosclerosis have produced mixed results, perhaps because of compensatory upregulation in the individual KO models. To clarify the role of transporter-mediated sterol efflux in this disease process, we transplanted BM from Abca1–/–Abcg1–/– mice into LDL receptor–deficient mice and administered a high-cholesterol diet. Compared with control and single-KO BM recipients, Abca1–/–Abcg1–/– BM recipients showed accelerated atherosclerosis and extensive infiltration of the myocardium and spleen with macrophage foam cells. In experiments with isolated macrophages, combined ABCA1 and ABCG1 deficiency resulted in impaired cholesterol efflux to HDL or apoA-1, profoundly decreased apoE secretion, and increased secretion of inflammatory cytokines and chemokines. In addition, these cells showed increased apoptosis when challenged with free cholesterol or oxidized LDL loading. These results suggest that the combined effects of ABCA1 and ABCG1 in mediating macrophage sterol efflux are central to the antiatherogenic properties of HDL.Keywords
This publication has 63 references indexed in Scilit:
- High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1Proceedings of the National Academy of Sciences of the United States of America, 2007
- Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivoJCI Insight, 2007
- CETP Inhibitors to Increase HDL Cholesterol LevelsThe New England Journal of Medicine, 2007
- Enhanced ABCG1 expression increases atherosclerosis in LDLr-KO mice on a western dietBiochemical and Biophysical Research Communications, 2006
- Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BIJournal of Lipid Research, 2006
- HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathwayJCI Insight, 2006
- Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesionsCell Metabolism, 2006
- Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic miceJCI Insight, 2005
- Free Cholesterol-loaded Macrophages Are an Abundant Source of Tumor Necrosis Factor-α and Interleukin-6Journal of Biological Chemistry, 2005
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesThe New England Journal of Medicine, 1989